The Guiding Role of Pharmaceutical Care in the Rational Drug Use of Bronchial Asthma

Objective: To investigate the guiding role of pharmaceutical care in the treatment of bronchial asthma. Methods: Eighty patients with bronchial disease admitted to our hospital from November 2008 to December 1818 were enrolled in this research. The computer program was used to generate random numbers. The method was divided into two groups: control group and observation group, 40 cases respectively. 40 patients in the control group were treated with normal medication according to the doctor's advice; 40 patients in the observation group were enrolled in the pharmacological care on the basis of the control group, and the rational drug use was compared between the two groups. Results: The incidence of adverse reactions in the observation group and the control group were 5.00% and 17.50%, respectively, and the difference was statistically significant (P<0.05); the incidence of medication error events in the observation group was 7.50%, which was significantly lower than that of the control group, which was 25.00%, and the difference was statistically significant (P<0.05). The medication errors mainly include improper administration, incorrect dosage, and unscientific administration. Conclusion: The guiding role of pharmaceutical care in bronchial asthma rational drug use can reduce medication error events and ensure rational drug use, which is worthy of popularization in clinical practice.